REACTA BIOTECH LIMITEDActive
Key figures
Like most small UK companies, REACTA BIOTECH LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2023Balance sheet structure
Filed accounts2020–2023
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Profit for the year | -901,848 | -1,363,721 | -792,051 | — |
| Cash at bank and in hand | 233,880 | 2,185,640 | 624,034 | 861,038 |
| Total assets | 536,084 | 2,643,253 | 1,025,765 | 3,305,461 |
| Total liabilities | 679,539 | 1,548,740 | 1,308,735 | — |
| Net assets / total equity | -62,187 | 1,216,964 | 424,913 | 1,989,814 |
| Average number of employees | 12 | 16 | 31 | 43 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: REACTA BIOTECH LIMITED
Company
REACTA BIOTECH LIMITED is a private limited company registered with Companies House under company number 08553682. It was incorporated on 3 Jun 2013. Its status is active. The registered office is in Deeside (CH5). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2023 (period ending 31 Dec 2023); the company files small company accounts. Net assets were £1,989,814, up 368.3% on the previous year. Cash at bank and in hand was £861,038. The company had an average of 43 employees. Figures are available for 4 financial years (2020–2023).
Control and charges
2 persons with significant control are registered. 1 of 3 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Sep 2026. The next confirmation statement is due by 23 Jun 2027.